menu
    • menu

    Company profile for Neomorph

    NEW Drugs in Dev: 2
    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    PMC Isochem is your partner for smart CDMOs of Intermediates, APIs, & excipients & a catalog of Intermediates & Generic APIs.

    Virtual Booth

    Contact Supplier

    Expand your portfolio with Egis- value-added generics, API capabilities, and reliable contract services to drive your growth.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Neomorph is a venture-backed biotechnology company that focuses on addressing critical challenges in human health by discovering and developing innovative medicines targeting 'undruggable targets.' The company's team consists of industry-leading experts in protein degradation and molecular glues, known for their groundbreaking discoveries in the field. Neomorph is dedicated to leadership in advancing the science and technology...
    Neomorph is a venture-backed biotechnology company that focuses on addressing critical challenges in human health by discovering and developing innovative medicines targeting 'undruggable targets.' The company's team consists of industry-leading experts in protein degradation and molecular glues, known for their groundbreaking discoveries in the field. Neomorph is dedicated to leadership in advancing the science and technology of molecular glue drug discovery. Simultaneously, the company is actively progressing a pipeline of projects through clinical development, aiming to bring transformative therapies to the forefront of healthcare.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    NeomorphUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    San Diego, CA
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://neomorph.com/index.html#home
    Linkedin
    Linkedin
    https://www.linkedin.com/company/xyramedical/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    BPI Europe

    BPI Europe

    Not Confirmed

    envelop Contact Supplier

    BPI Europe

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Neomorph Showcases Advances In Targeted Protein Degradation
    Neomorph Showcases Advances In Targeted Protein Degradation

    14 Apr 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/04/14/3273473/0/en/Neomorph-to-Highlight-Progress-in-Targeted-Protein-Degradation-Science-at-the-American-Association-for-Cancer-Research-Annual-Meeting.html

    GLOBENEWSWIRE
    14 Apr 2026
    Share Share
    Neomorph Announces Closing Of $100 Million Series B Financing
    Neomorph Announces Closing Of $100 Million Series B Financing

    13 Apr 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/04/13/3272523/0/en/Neomorph-Announces-Closing-of-100-Million-Series-B-Financing.html

    GLOBENEWSWIRE
    13 Apr 2026
    Share Share
    Neomorph Initiates NEO-811 Trial For Advanced Kidney Cancer
    Neomorph Initiates NEO-811 Trial For Advanced Kidney Cancer

    03 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/03/3231475/0/en/Neomorph-Announces-First-Patient-Dosed-in-Phase-1-2-Trial-Evaluating-NEO-811-For-the-Treatment-of-Locally-Advanced-or-Metastatic-Non-Resectable-Clear-Cell-Renal-Cell-Carcinoma.html

    GLOBENEWSWIRE
    03 Feb 2026
    Share Share
    AbbVie crafts $1.6B deal with molecular glue biotech Neomorph
    AbbVie crafts $1.6B deal with molecular glue biotech Neomorph

    24 Jan 2025

    // PRESS RELEASE

    https://news.abbvie.com/2025-01-23-AbbVie-and-Neomorph-Announce-Collaboration-to-Develop-Molecular-Glue-Degraders-for-Oncology-and-Immunology

    PRESS RELEASE
    24 Jan 2025
    Share Share
    Neomorph Appoints Klaus Wagner As Chief Medical Officer
    Neomorph Appoints Klaus Wagner As Chief Medical Officer

    14 Jan 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/neomorph-announces-appointment-of-dr-klaus-wagner-md-phd-as-chief-medical-officer-302350211.html

    PR NEWSWIRE
    14 Jan 2025
    Share Share
    Biogen and Neomorph Collaborate on Molecular Glue Degraders
    Biogen and Neomorph Collaborate on Molecular Glue Degraders

    29 Oct 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/10/29/2971307/0/en/Biogen-and-Neomorph-Announce-Multi-Target-Research-Collaboration-to-Discover-and-Develop-Molecular-Glue-Degraders-for-Alzheimer-s-Rare-and-Immunological-Diseases.html

    GLOBENEWSWIRE
    29 Oct 2024
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search